HERON THERAPEUTICS, INC. /DE/ (HRTX) Shareholders’ equity 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) shareholders’ equity at each fiscal year-end, per SEC filings.
$14.3MFY2025 · since FY2016: -$21.3M → $14.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.3M | +142.6% |
| FY2024 | -$33.7M | +0.9% |
| FY2023 | -$34.0M | -350.3% |
| FY2022 | $13.6M | -82.5% |
| FY2021 | $77.6M | -67.2% |
| FY2020 | $236.5M | -41.4% |
| FY2019 | $403.8M | +9.1% |
| FY2018 | $370.2M | +182.3% |
| FY2017 | $131.1M | +717.1% |
| FY2016 | -$21.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice